Epigenomics AG
Holding company investing in blood-based tests for early cancer detection.
ECX | F
Overview
Corporate Details
- ISIN(s):
- DE000A37FT41 (+2 more)
- LEI:
- 549300X1C4U862NDLN97
- Country:
- Germany
- Address:
- Bertha-Benz-Str. 5, 10557 Berlin
- Website:
- https://www.epigenomics.com/
Description
Epigenomics AG operates as a holding company dedicated to managing its assets and investments. The company's primary investment focus is on the field of molecular diagnostics, particularly in companies developing minimally invasive, blood-based tests for the early detection of cancer. This strategy leverages the company's historical expertise in the development of in vitro diagnostic products based on DNA methylation biomarkers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2013-10-24 00:00 |
Datum:24.10.2013
|
German | 8.1 KB | ||
| 2013-04-22 00:00 |
Datum:22.04.2013
|
German | 824.2 KB | ||
| 2013-04-18 00:00 |
Datum:18.04.2013
|
German | 572.8 KB | ||
| 2013-03-12 00:00 |
Datum:12.03.2013
|
German | 14.4 KB | ||
| 2013-01-31 00:00 |
Datum:31.01.2013
|
German | 27.1 KB | ||
| 2012-04-24 00:00 |
Datum:24.04.2012
|
German | 519.3 KB | ||
| 2012-04-18 00:00 |
Datum:18.04.2012
|
German | 825.6 KB | ||
| 2012-02-21 00:00 |
Datum:21.02.2012
|
German | 14.4 KB | ||
| 2011-05-16 00:00 |
Datum:16.05.2011
|
German | 497.1 KB | ||
| 2011-05-12 00:00 |
Datum:12.05.2011
|
German | 787.8 KB | ||
| 2011-05-04 00:00 |
Datum:04.05.2011
|
German | 15.6 KB | ||
| 2011-03-25 00:00 |
Datum:25.03.2011
|
German | 15.5 KB | ||
| 2010-05-07 00:00 |
Datum:07.05.2010
|
German | 843.6 KB | ||
| 2010-04-20 00:00 |
Datum:20.04.2010
|
German | 484.8 KB | ||
| 2010-03-15 00:00 |
Datum:15.03.2010
|
German | 15.6 KB |
Automate Your Workflow. Get a real-time feed of all Epigenomics AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Epigenomics AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Epigenomics AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-12-27 | Ho, Dr. Selwyn | Board | Buy | None | 4,200.00 EUR |
| 2022-12-23 | von Prondzynski, Heino | Supervisory board | Buy | None | 5,625.00 EUR |
| 2022-12-22 | Ahlers, Felix | Board | Other | None | 22,000.00 EUR |
| 2022-12-22 | Lubenow, Dr. Helge | Supervisory board | Buy | None | 1,934.20 EUR |
| 2022-12-20 | von Prondzynski, Heino | Supervisory board | Buy | None | 3,680.00 EUR |
| 2022-12-16 | Lindenice GmbH | Board | Buy | None | 7,400.00 EUR |
| 2022-12-16 | Ho, Dr. Selwyn | Board | Buy | None | 6,780.00 EUR |
| 2022-12-14 | von Prondzynski, Heino | Supervisory board | Buy | None | 40,000.00 EUR |
Peer Companies
